Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 3, 2010, Pages 275-281

  Ahn, Sun Young ^a   Choi, Yon Sik ^a   Koo, Hyun Jung ^a   Jeong, Jae Hoon ^a   Park, Wook Ha ^a   Kim, Minseok ^a   Piao, Ying ^a   Pak, Youngmi Kim ^a  

^a Age Related and Brain Diseases Research Center   (South Korea)

Author keywords

Akt PKB; Atherosclerosis; Insulin signaling; Mitochondrial dysfunction; oxLDL; VSMC

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; TRICIRIBINE; ZALCITABINE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; INSULIN RESISTANCE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; CELL COMPOSITION; CONFERENCE PAPER; PATHOPHYSIOLOGY; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CELL MOVEMENT; DNA PRIMERS; ELECTRON TRANSPORT COMPLEX IV; HUMANS; INSULIN; LIPOPROTEINS, LDL; LIVER; MITOCHONDRIA, MUSCLE; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

RATTUS;

EID: 76749110211     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2009.09.005     Document Type: Article

References (34)

1. Saltiel A.R., and Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
2. Zick Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005 (2005) pe4
3. Zhande R., Mitchell J.J., Wu J., and Sun X.J. Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol. Cell. Biol. 22 (2002) 1016-1026
4. Egawa K., Maegawa H., Shimizu S., Morino K., Nishio Y., Bryer-Ash M., Cheung A.T., Kolls J.K., Kikkawa R., and Kashiwagi A. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells. J. Biol. Chem. 276 (2001) 10207-10211
5. Vinciguerra M., and Foti M. PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling. Arch. Physiol. Biochem. 112 (2006) 89-104
6. Stratford S., Hoehn K.L., Liu F., and Summers S.A. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J. Biol. Chem. 279 (2004) 36608-36615
7. Farese R.V., Sajan M.P., and Standaert M.L. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes. Exp. Biol. Med. (Maywood) 230 (2005) 593-605
8. Lowell B.B., and Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 307 (2005) 384-387
9. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., and Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 (2003) 1140-1142
10. Kim J.A., Wei Y., and Sowers J.R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 102 (2008) 401-414
11. Park K.S., Nam K.J., Kim J.W., Lee Y.B., Han C.Y., Jeong J.K., Lee H.K., and Pak Y.K. Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E1007-E1014
12. Park S.Y., Choi G.H., Choi H.I., Ryu J., Jung C.Y., and Lee W. Depletion of mitochondrial DNA causes impaired glucose utilization and insulin resistance in L6 GLUT4myc myocytes. J. Biol. Chem. 280 (2005) 9855-9864
13. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., and Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54 (2005) 8-14
14. Choo H.J., Kim J.H., Kwon O.B., Lee C.S., Mun J.Y., Han S.S., Yoon Y.S., Yoon G., Choi K.M., and Ko Y.G. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49 (2006) 784-791
15. Glass C.K., and Witztum J.L. Atherosclerosis. the road ahead. Cell 104 (2001) 503-516
16. Han C.Y., and Pak Y.K. Oxidation-dependent effects of oxidized LDL: proliferation or cell death. Exp. Mol. Med. 31 (1999) 165-173
17. Han C.Y., Park S.Y., and Pak Y.K. Role of endocytosis in the transactivation of nuclear factor-kappaB by oxidized low-density lipoprotein. Biochem. J. 350 Pt. 3 (2000) 829-837
18. Kohn A.D., Summers S.A., Birnbaum M.J., and Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271 (1996) 31372-31378
19. Yoon Y.S., Byun H.O., Cho H., Kim B.K., and Yoon G. Complex II defect via down-regulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescence-associated growth arrest. J. Biol. Chem. 278 (2003) 51577-51586
20. Kuznetsov A.V., Veksler V., Gellerich F.N., Saks V., Margreiter R., and Kunz W.S. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat. Protoc. 3 (2008) 965-976
21. Pak Y.K., Kanuck M.P., Berrios D., Briggs M.R., Cooper A.D., and Ellsworth J.L. Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor. J. Lipid Res. 37 (1996) 985-998
22. Kim Y.S., Han C.Y., Kim S.W., Kim J.H., Lee S.K., Jung D.J., Park S.Y., Kang H., Choi H.S., Lee J.W., and Pak Y.K. The orphan nuclear receptor small heterodimer partner as a novel coregulator of nuclear factor-kappa b in oxidized low density lipoprotein-treated macrophage cell line RAW 264.7. J. Biol. Chem. 276 (2001) 33736-33740
23. Ryu J.W., Hong K.H., Maeng J.H., Kim J.B., Ko J., Park J.Y., Lee K.U., Hong M.K., Park S.W., Kim Y.H., and Han K.H. Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 864-870
24. Brito P.M., Devillard R., Negre-Salvayre A., Almeida L.M., Dinis T.C., Salvayre R., and Auge N. Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. Atherosclerosis 205 (2008) 126-134
25. Hundal R.S., Salh B.S., Schrader J.W., Gomez-Munoz A., Duronio V., and Steinbrecher U.P. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J. Lipid Res. 42 (2001) 1483-1491
26. Ma F.X., Zhou B., Chen Z., Ren Q., Lu S.H., Sawamura T., and Han Z.C. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J. Lipid Res. 47 (2006) 1227-1237
27. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
28. Medina D.J., Tsai C.H., Hsiung G.D., and Cheng Y.C. Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides. Antimicrob. Agents Chemother. 38 (1994) 1824-1828
29. Wagner B.K., Kitami T., Gilbert T.J., Peck D., Ramanathan A., Schreiber S.L., Golub T.R., and Mootha V.K. Large-scale chemical dissection of mitochondrial function. Nat. Biotechnol. 26 (2008) 343-351
30. Luo Z., Saha A.K., Xiang X., and Ruderman N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26 (2005) 69-76
31. Motoshima H., Goldstein B.J., Igata M., and Araki E. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 574 (2006) 63-71
32. Hardie D.G. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell. Sci. 117 (2004) 5479-5487
33. Bertrand L., Ginion A., Beauloye C., Hebert A.D., Guigas B., Hue L., and Vanoverschelde J.L. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H239-H250
34. Doran A.C., Meller N., and McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 812-819